This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Mar 8;315(10):1046-7.

doi: 10.1001/jama.2016.1825.

Time-to-Event Analysis

Juliana Tolles¹, Roger J Lewis²

Affiliations

Affiliations

¹ Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, California2Los Angeles Biomedical Research Institute, Torrance, California3David Geffen School of Medicine at UCLA, Los Angeles, California.
² Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, California2Los Angeles Biomedical Research Institute, Torrance, California3David Geffen School of Medicine at UCLA, Los Angeles, California4Berry Consultants LLC, Austin, Texas.

PMID: 26954413
DOI: 10.1001/jama.2016.1825

Comment

Time-to-Event Analysis

Juliana Tolles et al. JAMA. 2016.

. 2016 Mar 8;315(10):1046-7.

doi: 10.1001/jama.2016.1825.

Authors

Juliana Tolles¹, Roger J Lewis²

Affiliations

¹ Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, California2Los Angeles Biomedical Research Institute, Torrance, California3David Geffen School of Medicine at UCLA, Los Angeles, California.
² Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, California2Los Angeles Biomedical Research Institute, Torrance, California3David Geffen School of Medicine at UCLA, Los Angeles, California4Berry Consultants LLC, Austin, Texas.

PMID: 26954413
DOI: 10.1001/jama.2016.1825

No abstract available

PubMed Disclaimer

Comment on

Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.
Nissen SE, Wolski KE, Prcela L, Wadden T, Buse JB, Bakris G, Perez A, Smith SR. Nissen SE, et al. JAMA. 2016 Mar 8;315(10):990-1004. doi: 10.1001/jama.2016.1558. JAMA. 2016. PMID: 26954408 Clinical Trial.

Similar articles

Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion: A Study Interrupted.
Sharfstein JM, Psaty BM. Sharfstein JM, et al. JAMA. 2016 Mar 8;315(10):984-6. doi: 10.1001/jama.2016.1461. JAMA. 2016. PMID: 26954405 No abstract available.
Company is blamed for early halt of trial into obesity treatment.
Wise J. Wise J. BMJ. 2016 Mar 8;352:i1363. doi: 10.1136/bmj.i1363. BMJ. 2016. PMID: 26962129 No abstract available.
Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.
Nissen SE, Wolski KE, Prcela L, Wadden T, Buse JB, Bakris G, Perez A, Smith SR. Nissen SE, et al. JAMA. 2016 Mar 8;315(10):990-1004. doi: 10.1001/jama.2016.1558. JAMA. 2016. PMID: 26954408 Clinical Trial.
Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.
Verpeut JL, Bello NT. Verpeut JL, et al. Expert Opin Drug Saf. 2014 Jun;13(6):831-41. doi: 10.1517/14740338.2014.909405. Epub 2014 Apr 28. Expert Opin Drug Saf. 2014. PMID: 24766397 Review.
Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity.
Ali KF, Shukla AP, Aronne LJ. Ali KF, et al. Expert Rev Clin Pharmacol. 2016;9(1):27-34. doi: 10.1586/17512433.2016.1100072. Epub 2015 Oct 29. Expert Rev Clin Pharmacol. 2016. PMID: 26512740 Review.

See all similar articles

Cited by

Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder.
Krans EE, Kim JY, James AE 3rd, Kelley DK, Jarlenski M. Krans EE, et al. Drug Alcohol Depend. 2018 Apr 1;185:207-213. doi: 10.1016/j.drugalcdep.2017.12.023. Epub 2018 Feb 14. Drug Alcohol Depend. 2018. PMID: 29462768 Free PMC article.
Scalable and Robust Regression Methods for Phenome-Wide Association Analysis on Large-Scale Biobank Data.
Bi W, Lee S. Bi W, et al. Front Genet. 2021 Jun 15;12:682638. doi: 10.3389/fgene.2021.682638. eCollection 2021. Front Genet. 2021. PMID: 34211504 Free PMC article. Review.
Predicting colorectal polyp recurrence using time-to-event analysis of medical records.
Harrington LX, Wei JW, Suriawinata AA, Mackenzie TA, Hassanpour S. Harrington LX, et al. AMIA Jt Summits Transl Sci Proc. 2020 May 30;2020:211-220. eCollection 2020. AMIA Jt Summits Transl Sci Proc. 2020. PMID: 32477640 Free PMC article.
Reduced SARS-CoV-2 Infection Rates in Lab Workers Conducting Nucleic Acid Testing: Controlling for the Healthy Worker Effect.
Lin LQ, Chen YY, Lin GZ, Shen X, Yang TC, Liu LL, Xiao Y. Lin LQ, et al. J Epidemiol Glob Health. 2025 Jan 29;15(1):10. doi: 10.1007/s44197-025-00343-8. J Epidemiol Glob Health. 2025. PMID: 39878891 Free PMC article.
Survival analysis-part 2: Cox proportional hazards model.
Deo SV, Deo V, Sundaram V. Deo SV, et al. Indian J Thorac Cardiovasc Surg. 2021 Mar;37(2):229-233. doi: 10.1007/s12055-020-01108-7. Epub 2021 Jan 2. Indian J Thorac Cardiovasc Surg. 2021. PMID: 33642726 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information